Listed by the USPTO as WILLIS, DOUGLAS M
Tech Center 1600 • Art Units: 1624 1629 1691
This examiner grants 82% of resolved cases
WILLIS, DOUGLAS M is assigned to tech center 1600 and art unit 1624. His profile contains 1822 resolved cases, with an allowance rate of 82.4%. Median time to allowance is 688 days, and the interview lift is 19.7%. The extensive record shows frequent allowances and a median timeline under two years, with interviews producing a measurable association.
The listed companies are Insilico Medicine Ip Limited, Nuvalent, Inc., and Kineta Inc. The firms are MCCARTER & ENGLISH, LLP BOSTON, AMSTER, ROTHSTEIN & EBENSTEIN LLP, and BIRCH STEWART KOLASCH & BIRCH, LLP. Practitioners can use the profile to plan around a large life sciences docket with comparatively direct timing indicators.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18694848 | COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT | Non-Final OA | MIRATI THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy82.4% of resolved applications examined by Douglas M Willis were allowed (1,822 resolved cases), compared with 54.6% across Art Unit 1624 over the last five years.
This examiner's interview lift is +19.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Douglas M Willis took 688 days on average from filing to allowance.
Douglas M Willis examines applications in Art Unit 1624 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
